Women who experience menopause before the age of 40 face a significantly elevated lifetime risk of heart attacks compared to women who go through the transition later, according to a new study published Wednesday in JAMA Cardiology. The research found that women with premature menopause had 40% more fatal and nonfatal heart attacks throughout the course of their lives than those who reached menopause after 40, adding to a growing body of evidence linking reproductive history to long-term cardiovascular health.
The findings carry particular urgency for Black women, who the study found were three times as likely as white women to report having experienced premature menopause. Research stretching back decades has consistently documented that Black women tend to reach menopause at earlier ages than white women, with some studies pointing to environmental factors and chronic psychosocial stress as contributing causes. The combination of higher premature menopause rates and already elevated cardiovascular disease risk in this population makes the findings especially significant from a public health perspective.
What premature menopause does to the cardiovascular system
The average age of menopause, defined as 12 consecutive months without a menstrual period, is 51 to 52. When menopause occurs before 40 it is classified as premature, and when it occurs between 40 and 45 it is considered early. Both categories carry cardiovascular implications that researchers are increasingly arguing should be factored into routine heart health assessments.
Dr. Priya Freaney, the paper’s lead author and director of Women’s Heart Care at Northwestern University, described the metabolic cascade that menopause triggers in terms that make the cardiovascular connection clear. Lipid levels rise by approximately 20%, blood pressure profiles worsen, physical activity tends to decrease due to severe menopausal symptoms, body fat redistributes toward the abdomen, muscle mass declines and fat mass increases. When these changes occur in a woman’s 30s rather than her early 50s, the cardiovascular system is exposed to that compounding risk for a significantly longer period of time.
Dr. Freaney drew an analogy to pregnancy as a way of framing how menopause should be viewed in clinical settings. Just as pregnancy is considered a kind of cardiovascular stress test that can reveal underlying risk, menopause serves as a window into a woman’s long-term heart health. The age at which that window opens matters considerably.
A pattern confirmed across multiple studies
The JAMA Cardiology paper is not the first to identify the link between premature menopause and elevated coronary heart risk, but it reinforces a pattern that researchers are now arguing demands a formal change in how cardiovascular risk is assessed in women. A large 2019 study of women in Britain found significant increases across a broad range of cardiovascular conditions in women who had undergone premature menopause naturally, including coronary artery disease, heart failure, ischemic stroke, blood clots and atrial fibrillation. Women who experienced premature menopause because their ovaries had been surgically removed faced even higher risks than those whose early menopause occurred naturally.
The consistency of findings across multiple studies and populations strengthens the case that premature menopause is not simply a marker associated with cardiovascular risk but a contributing factor that accelerates the biological processes underlying it.
What this means for women and their doctors
Dr. Freaney’s central recommendation is that reproductive history, including the age at which a woman reaches menopause, should be incorporated into standard cardiovascular risk assessments rather than treated as separate from heart health evaluations. Currently, risk calculators used in clinical practice do not consistently account for menopause timing, meaning that women who reached menopause before 40 may be receiving risk assessments that underestimate their true cardiovascular exposure.
For women who experienced premature menopause, the findings underscore the importance of proactive conversations with their doctors about cardiovascular monitoring, lifestyle interventions and the potential role of hormone therapy in managing the metabolic changes that accompany early estrogen loss. The research does not prescribe a single course of action, but it makes clear that early menopause is a clinically meaningful data point that should not be overlooked when evaluating a woman’s long-term heart health trajectory.
